Tokyo Tape
Sign in
← Immuno-Biological Laboratories

Half-year report · Q2

4570.TEDINET S100URML
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥444m2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥817m2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥366m2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥68m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥13m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥64m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥125m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥31m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥64m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥30m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥72m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥187m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥27m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥72m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥27m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥1.6bnat 2024-09-30Cons.Assets
Total assets¥1.6bnat 2024-03-31Cons.Assets
Total assets¥1.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥309mat 2024-09-30Cons.Liabilities
Total liabilities¥353mat 2024-03-31Cons.Liabilities
Net assets / equity¥1.3bnat 2024-09-30Cons.Net assets
Net assets / equity¥1.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥1.1bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥731mat 2024-09-30Cons.Cash and deposits
Cash and deposits¥734mat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥666mat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥675mat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥566mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥562mat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥77m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥134m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥44m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥24m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥39m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥991,0002023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥3m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥7.682024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.052023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥2.882023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio81.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00986-000Cosmeticsreportable segmentrevenue2024-04-01 → 2024-09-30¥3m
jpcrp040300-q2r_E00986-000Cosmeticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥3m
jpcrp040300-q2r_E00986-000Cosmeticsreportable segmentsegment profit2024-04-01 → 2024-09-30¥723,000
jpcrp040300-q2r_E00986-000Immunity Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥441m
jpcrp040300-q2r_E00986-000Immunity Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥441m
jpcrp040300-q2r_E00986-000Immunity Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥67m
—segment totalrevenue2024-04-01 → 2024-09-30¥444m
—segment totalrevenue external2024-04-01 → 2024-09-30¥444m
—segment totalsegment profit2024-04-01 → 2024-09-30¥68m
jpcrp040300-q2r_E00986-000Cosmeticsreportable segmentrevenue2023-04-01 → 2023-09-30¥2m
jpcrp040300-q2r_E00986-000Cosmeticsreportable segmentrevenue external2023-04-01 → 2023-09-30¥2m
jpcrp040300-q2r_E00986-000Cosmeticsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥3m
jpcrp040300-q2r_E00986-000Immunity Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥363m
jpcrp040300-q2r_E00986-000Immunity Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥363m
jpcrp040300-q2r_E00986-000Immunity Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥16m
—segment totalrevenue2023-04-01 → 2023-09-30¥366m
—segment totalrevenue external2023-04-01 → 2023-09-30¥366m
—segment totalsegment profit2023-04-01 → 2023-09-30¥13m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 437
ItemContextValueUnit
Loss on valuation of investment securities elPrior1YTDDuration166000JPY
Loss on valuation of investment securities elCurrentYTDDuration－JPY
Impairment loss elPrior1YTDDuration602000JPY
Impairment loss elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration769000JPY
Extraordinary lossCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration29869000JPY
Income before income taxesCurrentYTDDuration64211000JPY
Income taxes currentPrior1YTDDuration3007000JPY
Income taxes currentCurrentYTDDuration617000JPY
Income taxes deferredPrior1YTDDuration－JPY
Income taxes deferredCurrentYTDDuration-7918000JPY
Income taxesPrior1YTDDuration3007000JPY
Income taxesCurrentYTDDuration-7300000JPY
Profit lossPrior1YTDDuration26861000JPY
Profit lossCurrentYTDDuration71512000JPY
Profit loss attributable to owners of parentPrior1YTDDuration26861000JPY
Profit loss attributable to owners of parentCurrentYTDDuration71512000JPY
Profit lossPrior1YTDDuration26861000JPY
Profit lossCurrentYTDDuration71512000JPY
Comprehensive incomePrior1YTDDuration26861000JPY
Comprehensive incomeCurrentYTDDuration71512000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration26861000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration71512000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration29869000JPY
Income before income taxesCurrentYTDDuration64211000JPY
Depreciation and amortization ope cfPrior1YTDDuration－JPY
Depreciation and amortization ope cfCurrentYTDDuration6059000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-6697000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration－JPY
Interest and dividends income ope cfPrior1YTDDuration-47000JPY
Interest and dividends income ope cfCurrentYTDDuration-91000JPY
Interest expenses ope cfPrior1YTDDuration533000JPY
Interest expenses ope cfCurrentYTDDuration619000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-2820000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration3067000JPY
Impairment loss ope cfPrior1YTDDuration602000JPY
Impairment loss ope cfCurrentYTDDuration－JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration24935000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration12189000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-6904000JPY
Decrease increase in inventories ope cfCurrentYTDDuration422000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-2298000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration7064000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-6801000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-6356000JPY
Loss gain on valuation of investment securities ope cfPrior1YTDDuration166000JPY
Loss gain on valuation of investment securities ope cfCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass